Target intelligence / Profile preview

Nuclear protein localization protein 4 cofactor–valosin-containing protein segregase complex (NPL4–p97/VCP segregase complex)

Target
NPL4–p97/VCP segregase complex
Molecular classification
AAA+ ATPase cofactor/adaptor complex[2][3], Protein quality control machinery[2][3], Segregase enzyme system[1][2], Ubiquitin-proteasome system component[3]
01

Overview

The nuclear protein localization protein 4 cofactor–valosin-containing protein segregase complex is a multi-protein assembly central to eukaryotic cellular proteostasis. The core consists of valosin-containing protein (VCP), also known as p97—a highly conserved AAA+ ATPase—and its major adaptors/cofactors NPLOC4 (nuclear protein localization homolog) and UFD1L. This ternary “segregase” uses energy from ATP hydrolysis to extract ubiquitinated substrates from membranes, chromatin, ribosomes, or large macromolecular assemblies so they can be degraded by the proteasome. The process is essential for endoplasmic reticulum-associated degradation (ERAD), mitochondrial quality control, DNA replication/repair regulation during cell cycle progression, membrane fusion events after mitosis, and more. Dysfunctional activity—whether through mutation or pharmacologic inhibition—can result in severe pathologies including neurodegeneration and cancer susceptibility/resistance due to altered clearance capacity for misfolded/damaged proteins.[1][2][3][5]

Other names
NPL4–VCP complexNPL4–p97 complexUfd1-Npl4-p97 complexValosin-containing protein (VCP)/p97 segregase adaptor NPL4[3][5]p97-Ufd1-Npl4 complex[5]
02

Mechanism of action

Disulfiram/CuET: - Induces clustering/aggregation of NPL4, leading to dysfunction of the VCP/p97 segregase pathway. - Causes accumulation of polyubiquitinated proteins due to impaired extraction/degradation. - Results in proteotoxic stress selectively toxic to cancer cells with high proteasome dependency.[3] Other potential mechanisms: - Inhibition or modulation of ATP hydrolysis or adaptor binding could disrupt substrate processing.

03

Biological functions

Protein quality control and homeostasis (ER-associated degradation, mitochondria-associated degradation)[2][3]Extraction/segregation of ubiquitinated proteins from membranes, chromatin, or complexes for proteasomal degradation (“segregase” activity)[1][2][5]Regulation of cell cycle and mitosis via substrate processing/removal from chromatin and other structures[2][5]Participation in autophagy and vesicle trafficking/membrane fusion events (context-dependent)[2]
04

Disease associations

Cancer (targeted by disulfiram/CuET; implicated in tumor cell survival/proteostasis stress)[3]Neurodegenerative diseases (e.g., Huntington’s disease; functional deficiency leads to aggregate accumulation)[3]Inclusion body myopathy, Paget’s disease of bone, frontotemporal dementia (mutations in p97/VCP cause these disorders)[1]
05

Safety considerations

Potential safety concerns include: - Disruption can lead to global impairment in cellular protein homeostasis. - Risk for neurotoxicity/myopathy if normal function is excessively inhibited—mirroring genetic diseases caused by loss-of-function mutations.[1][3] - Broad impact on essential cellular processes such as ERAD and DNA repair.
06

Interacting drugs

Disulfiram/CuET (copper diethyldithiocarbamate), which targets the NPL4 component of the VCP/p97 segregase complex in cancer therapy research[3]
07

Biomarkers

No specific clinical biomarkers are established for patient selection or efficacy monitoring related directly to this target. However: - Accumulation patterns of polyubiquitinated proteins may serve as a pharmacodynamic marker in experimental settings.[3]

Beyond the preview

Go deeper on Nuclear protein localization protein 4 cofactor–valosin-containing protein segregase complex (NPL4–p97/VCP segregase complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear protein localization protein 4 cofactor–valosin-containing protein segregase complex (NPL4–p97/VCP segregase complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call